Overview:

• Benchmark indices settled in the red as the Sensex declined 375 points to 84,622.01 and Nifty fell below 26,000.

• Pharma, metal, and IT sectors led the market lower, with Dr. Reddy's Labs falling more than 4%.

• L&T and PB Fintech gained on strong Q2 results, while Vodafone Idea plummeted close to 7% following a negative Supreme Court ruling.

Indian stock market today showed bearish sentiments on Thursday, October 30, 2025, with the benchmark indices trading in the negative amidst widespread selling pressure. BSE Sensex dropped 375.12 points, or 0.44%, to 84,622.01, while Nifty 50 dropped 104.25 points, or 0.40%, to 25,949.65. Here’s what happened in Indian stock market today, based on Moneycontrol Live Updates.

Sectoral Performance Weighs on Markets

Nifty Pharma was the biggest loser, falling 1.3% in the session. The pharma space came under severe pressure after Dr. Reddy's Laboratories issued a notice of non-compliance by Canadian drug regulators over its Semaglutide injection. The stock fell 4.28%, which was the top loser on Nifty 50 index.

The stock market today also witnessed weakness within Nifty Metal and Nifty FMCG indices, each of which declined 0.7%. Technology stocks too were under strain, with Nifty IT depreciating 0.5%. The IT index dipped 236.45 points to 35,853.65 as investors feared a weak global economic outlook.

Nifty Bank index also saw a relatively modest fall of 0.29%, dropping 166.55 points to 58,218.70. In the banking and finance shares, Nifty Private Bank fell 0.5%, while Nifty Realty and Nifty Oil & Gas also lost 0.3% each during the trading session.

Top Gainers and Losers on Nifty 50

Larsen & Toubro was the top gainer on Nifty 50, rising 1.31% to Rs. 4,010. The engineering major's robust rally followed after it posted a 16% rise in consolidated net profit to Rs. 3,926 crore for the September 30, 2025 quarter.

The company's operating revenue increased 10% to Rs. 67,984 crore, which boosted investor confidence. Coal India rose 0.88%, and Shriram Finance gained 0.83%. Both Maruti Suzuki and Titan Company rose 0.45%.

The biggest losers on Nifty 50 include HDFC Life, which fell 1.62%, Sun Pharma, down 1.56%, and Bharti Airtel, down 1.45%. Power Grid Corporation declined 1.29% for the session.

Also Read: IRFC Share Price Gains 1.25% to Rs. 124.30, But Analysts Warn of Weak Trend

Corporate Earnings Drive Individual Stock Movements

PB Fintech, the parent entity of Policybazaar, zoomed 3.59% following the posting of an impressive 164% year-on-year increase in profit to Rs. 134.89 crore. The revenue of the firm increased 38% to Rs. 1,613.5 crore, depicting solid business strength. BHEL shares rose 3.90% on account of good earnings growth, reflecting investors’ desire for firms offering good financial performance.

Though Vodafone Idea witnessed heavy selling pressure, dropping 6.94% after the Supreme Court came out with its written judgment on the company's plea for adjusted gross revenue (AGR). The Court made it clear that the relief is limited to Vodafone Idea and extends only to the balance AGR dues of Rs. 9,450 crore raised for the period up to FY2016-17.

Shaily Engineering Plastics fell 13% in its steepest one-day fall since May 2022, as fears over revenue visibility mounted following Dr. Reddy's regulatory failure in Canada. The pharmaceutical firm is one of Shaily's biggest customers.

Market Breadth and Trading Activity

The NSE advance-decline ratio was 1,052 advancing stocks to 1,629 declining stocks, reflecting negative market breadth. The BSE Smallcap index was relatively strong, falling only 0.16% to 54,037.27.

On an institutional activity front, Foreign Institutional Investors (FII) were net sellers, selling Rs. 2,540.16 crore worth of shares on 29th October. Domestic Institutional Investors (DII) came to the rescue and bought Rs. 5,692.81 crore in the same timeframe.

Currency and Global Factors

The Indian rupee opened weaker at 88.40 versus the dollar, showing signs of continued currency stress. Meanwhile, gold prices maintained their recent decline as Federal Reserve Chairman Jerome Powell extinguished expectations of a December rate cut. The precious metal has pulled back from its all-time high above $4,380 an ounce.

Asian markets closed mixed after the US Federal Reserve made a quarter-point rate reduction, as investors looked to a critical meeting between US President Donald Trump and Chinese President Xi Jinping.

Also Read: Stock Market Today: Sensex Jumps 300 Points, SAIL Up 7.3%, Adani Green Rallies 6%

Market Outlook

Stock market today indicates further volatility in the backdrop of global economic uncertainty and corporate earnings season. Although strong domestic institutional demand offers cushioning, foreign investor withdrawals are a worry. Investors need to watch for further direction in the forthcoming sessions with upcoming earnings releases and policies of global central banks.

FAQs

1. Why did the Indian stock market decline today?

The market tumbled amid wide-based selling in pharma, metal, and IT shares. Poor global cues, profit-taking, and FII outflows of more than Rs. 2,500 crore weighed heavily on the benchmark indices.

2. Which industry sectors were the worst performers in today's session?

The Nifty Pharma index was the worst laggard, down 1.3%, followed by Nifty Metal and Nifty FMCG, each down 0.7%. IT stocks also declined amid fears about the global economy.

3. Which were the Nifty 50 top gainers today?

Larsen & Toubro topped the list with a 1.31% increase following robust quarterly numbers. Coal India, Shriram Finance, Maruti Suzuki, and Titan Company also ended higher.

4. What caused the sharp decline in Dr. Reddy's Laboratories' stock price?

Dr. Reddy's shares fell more than 4% after the firm received a non-compliance notice from Canadian regulators regarding its Semaglutide injection, widening regulatory and export-related concerns for the firm.

5. What is the market prognosis for the upcoming sessions?

Experts anticipate ongoing volatility amid earnings releases and global rate policy changes. Support from strong DII buying is possible, but foreign outflows and global uncertainty remain the primary risks.